Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01102205
Other study ID # tastoshashi
Secondary ID
Status Completed
Phase N/A
First received April 9, 2010
Last updated June 11, 2013
Start date April 2010
Est. completion date October 2010

Study information

Verified date June 2013
Source Vakif Gureba Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority Turkey: Ministry of Health
Study type Observational

Clinical Trial Summary

Oxidative stress leads to or accompanies with numerous disease. Oxidative balance in subclinical hypothyroid or euthyroid state in Hashimoto disease are not known. Effect of levothyroxine therapy on oxidative balance are also not known in hashimoto disease.


Description:

oxidative stress markers will be measured initially(TAS,TOS,OSI,PARAOXONASE,ARYLESTERASA,PON1 PHENOTYPİNG,LİPİDPEROXİD).After 3 months therapy with levothyroxine measurements will be repeated except PON1 phenotyping.


Recruitment information / eligibility

Status Completed
Enrollment 130
Est. completion date October 2010
Est. primary completion date April 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria:

- age more than 18 years

Exclusion Criteria:

- inability to give a written consent

- other conditions and drug usage affect oxidative stress

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Vakif Gureba Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Vakif Gureba Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Poxidative stress markers After levotren therapy No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05975866 - The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato N/A
Completed NCT02725879 - FGF-21 Levels and RMR in Children and Adolescents With Hashimoto's Thyroiditis (THYROMETABOL)
Completed NCT00552487 - Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis N/A
Recruiting NCT04778865 - Effect of Treatment for Vitamin D Deficiency on Thyroid Function and Autoimmunity in Hashimoto's Thyroiditis. N/A
Completed NCT04752202 - The Influence of Reducing Diets on Changes in Thyroid Parameters in Obese Women With Hashimoto's Disease N/A
Enrolling by invitation NCT04789993 - Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up
Recruiting NCT05435547 - Preoperative Corticosteroids in Autoimmune Thyroid Disease Phase 4
Completed NCT05949671 - Evaluation of the Effect of Gluten-Free Diet and Mediterranean Diet N/A
Not yet recruiting NCT04613323 - Management of Thyroid Function in Hashimoto's Thyroiditis During Pregnancy
Recruiting NCT04693936 - Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis N/A
Completed NCT04682340 - Analysis of BPA Concentration in Serum in Women of Reproductive Age With Autoimmune Thyroid Disease
Completed NCT05077865 - Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult Subjects Phase 1